Try our beta test site
IMPORTANT: Listing of a study on this site does not reflect endorsement by the National Institutes of Health. Talk with a trusted healthcare professional before volunteering for a study. Read more...
17 studies found for:    99mTc-MDP
Show Display Options
Rank Status Study
1 Recruiting 18F-NaF-PET/MR vs 99mTc-MDP-SPECT/CT to Detect Bone Metastases in Prostate Cancer Patients.
Conditions: Bone Metastases;   Prostate Cancer
Interventions: Other: scintigraphy 99mTc-MDP-SPECT/CT.;   Other: 18F-NaF-PET/MR
2 Not yet recruiting Biokinetics Study for Tc-99m MDP in Pediatric Molecular Imaging
Condition: Skeletal Injury
Interventions: Drug: Tc-99M MDP;   Other: Modification in acquisition protocol
3 Active, not recruiting F-18 PET Bone Scans Versus Tc-99m Bone Scans for the Diagnosis of Bone Metastases
Conditions: Cancer;   Bone Metastases
Interventions: Device: F-18 PET bone scan;   Device: Tc-99m bone scan
4 Enrolling by invitation Sodium Pertechnetate (99Tc) Injection Generator: 99mTc From Neutron-activation 99Mo v 99mTc From Fission 99Mo
Condition: Cancer of Bone
Interventions: Drug: 99mTc MDP Injection:fission;   Drug: 99mTc MDP Injection:neutron-bombardment
5 Unknown  18F-NaF PET in Detecting Metastatic Bone Lesion for Patients With Cancer.
Condition: Cancer
6 Unknown  F18PET/CT Versus TC-MDP Scanning to Detect Bone Mets
Condition: Bone Metastases
Intervention: Device: Bone Scan: F18-Fluoride PET/CT or TC-MDP
7 Recruiting Combined 18F NaF/18F FDG PET/MRI for Detection of Skeletal Metastases
Condition: Cancer
Interventions: Procedure: Positron Emission Tomography;   Procedure: Magnetic Resonance Imaging;   Radiation: Fludeoxyglucose F-18;   Radiation: Fluorine F 18 Sodium Fluoride
8 Completed Whole Body Fluorine F 18 Sodium Fluoride PET/CT Scan and Whole Body MRI in Finding Bone Metastases in Patients With Prostate Cancer
Conditions: Bone Metastases;   Recurrent Prostate Cancer;   Stage I Prostate Cancer;   Stage IIA Prostate Cancer;   Stage IIB Prostate Cancer;   Stage III Prostate Cancer;   Stage IV Prostate Cancer
Interventions: Procedure: magnetic resonance imaging;   Radiation: fluorine F 18 sodium fluoride;   Procedure: positron emission tomography;   Procedure: computed tomography;   Radiation: technetium Tc 99m methylene diphosphonate;   Other: laboratory biomarker analysis
9 Unknown  F18-Flouride PET/CT in Acute Knee Injury
Condition: Knee Injury
10 Recruiting NaF/FDG PET/MRI in Measuring Response to Radium Ra 223 Dichloride in Patients With Metastatic Hormone-Resistant Prostate Cancer
Conditions: Hormone-Resistant Prostate Cancer;   Metastatic Malignant Neoplasm in the Bone;   Metastatic Prostate Carcinoma
Interventions: Procedure: Contrast-enhanced Magnetic Resonance Imaging;   Drug: Fludeoxyglucose F-18;   Drug: Fluorine F 18 Sodium Fluoride;   Procedure: Magnetic Resonance Imaging;   Procedure: Positron Emission Tomography
11 Completed
Has Results
Evaluation of the Effects of Teriparatide on Skeleton Images in Postmenopausal Women With Osteoporosis
Condition: Osteoporosis
Intervention: Drug: teriparatide
12 Recruiting C-Acetate PET/CT Imaging to Evaluate Treatment Changes in Prostate Cancer
Condition: Prostate Cancer Patients
Interventions: Drug: 11C-Acetate;   Drug: Ra-223 therapy
13 Recruiting Sestamibi Scans In Thyroglobulin Positive Scan Negative Differentiated Thyroid Cancer Patients
Condition: Thyroid Cancer
Intervention: Radiation: 99mTc sestamibi
14 Recruiting 18F-NaF PET Imaging for Bone Scintigraphy
Condition: Bone Metastases From Breast or Prostate Cancer
Interventions: Procedure: NaF PET/CT Imaging;   Procedure: 99mTc-medronate whole body bone scan with SPECT;   Drug: 18F-Sodium Fluoride (NaF)
15 Unknown  18F-FDG PET Metabolic Phenotype in Evaluating Therapeutic Response for Breast Cancer Patients With Bone Metastases.
Conditions: Breast Cancer;   18F-FDG PET
16 Unknown  Observational Pilot Study of 18F-Sodium Fluoride (Na18F) Whole Body Positron Emission Tomography (PET) Scans for Imaging Bone
Condition: Bone Scan
Intervention: Other: 18F-Sodium Fluoride (Na18F)
17 Recruiting 99mTc-3PRGD2 SPECT/CT in Rheumatoid Arthritis Patients
Condition: Rheumatoid Arthritis
Intervention: Drug: 99mTc-3PRGD2

Study has passed its completion date and status has not been verified in more than two years.